$72.290
+1.504 (+2.08%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TARS Prediction & Forecast by Similar Chart Analysis
Alphio's TARS stock price prediction model matches the current Tarsus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $74.10 (+2.51%). The 1-week path is $74.67 (+3.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Tarsus Pharmaceuticals Inc Stock?
Tarsus Pharmaceuticals is a good buy right now due to its strong acquisition strategy and robust revenue growth. The current price is $73.16, with a forward P/E of 68.03 indicating potential for future earnings growth. Additionally, the company reported a gross margin of 93% in Q2 2026, reflecting strong profitability. However, the main risk is the negative net income of $18.55 million in Q2 2026, which investors should consider.
TARS stock price ended at $72.29 on Wednesday, after rising +2.08%
Tarsus Pharmaceuticals Inc (TARS) last closed at $72.29, gaining +2.08%. These facts feed the 1-day and 1-week TARS price prediction above.
Forecast Drivers
Tarsus Pharmaceuticals Inc (TARS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TARS, ranked by similarity.
Seasonality analysis for TARS
Historically the probability of a positive October return for TARS is 80.70%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TARS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $104.14 | $127.89 | $153.02 | +76.91% |
| Nov 2026 | $70.73 | $114.56 | $154.39 | +58.47% |
| Dec 2026 | $99.13 | $101.61 | $147.86 | +40.56% |
In 2026, Tarsus Pharmaceuticals Inc (TARS) is projected to range from $70.73 to $154.39.
Tarsus Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Tarsus Pharmaceuticals Inc is projected to average $127.89, with a low of $104.14 and high of $153.02.
In Nov 2026, Tarsus Pharmaceuticals Inc is projected to average $114.56, with a low of $70.73 and high of $154.39.
In Dec 2026, Tarsus Pharmaceuticals Inc is projected to average $101.61, with a low of $99.13 and high of $147.86.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.